Delivery Order SPE2DB20D7059-SPE2DB24FQAB0
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,635.58 for the supply of JANUMET 50-1,000 MG TABLET 180S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 27, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,530.50 for JANUMET 50-1,000 MG TABLET 180S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on March 10, 2022, with a completion date of March 11, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $14,166.66 for the supply of JANUMET 50-1,000 MG TABLET 180S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,234.02 for the supply of JANUMET 50-1,000 MG TABLET 180S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 8, 2022. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation, indicating it was competed on an open market basis. Amerisourcebergen is a major...
- This federal contract award, valued at $7,466.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with an ultimate completion date of January 24, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $5,424.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product JANUMET 50-1,000 MG TABLET 180S, with a completion date of February 23, 2024. This is a firm fixed-price delivery order contract, and it was awarded without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The $3,316.70 firm fixed-price delivery order, which has an ultimate completion date of March 28, 2022, is for the provision of JANUMET 50-500 MG TABLET 180S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,874.35 for the supply of JANUMET XR 50-1,000 mg tablets. The contract was awarded on May 1, 2023, with a completion date of May 2, 2023, and has a firm fixed price. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that procures pharmaceutical and medical supplies for the Department of Defense and other federal agencies....
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was granted to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,622.67 firm fixed-price delivery order is for 180 units of the pharmaceutical product JANUMET 50-1,000 MG TABLET. The award has an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $4,946.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of JANUMET 50-500 MG TABLET 180S, a pharmaceutical product, with an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FQAB0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,212.44 for the supply of JANUMET 50-1,000 MG TABLET 180S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 29, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 2/28/24 |